跳至主要内容
临床试验/NL-OMON31793
NL-OMON31793已完成4 期

The effects of aspirin on the platelet function of healty volunteers and of patients with occlusive arterial vascular disease. - EAP

Academisch Ziekenhuis Maastricht0 个研究点目标入组 36 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • population A: healthy, BMI <27.5, non smoker.
  • Population B1: stroke in medical history (large vessel disease) between 01-07-01 and 01-07-06. No- recurrent stroke. Therapie with carbasalate calcium 100mg daily.
  • Population B2: recurrent stroke in medical history despite therapy with carbasalate calcium 100mg daily. First stroke between 01-07-01 and 01-07-06. last stoke > 3 months ago.

排除标准

  • Population A: any contra-indication for carbasalate calcium. The use of NSAIDs. Cardiovascular disease, Diabetes Mellitus. recent operation (3 months)
  • Population B: therapy with clopidogrel, NSAIDs, oral anticoagulation therapy. Known malignancy, operation < 3 months ago. Cardiovascular event < 3 months ago. Known hematologic disease. Thrombocytopenia(< 100000/mm3), thrombocytosis (> 400 000/mm3), anemia, polycytemia (Ht>50%)

研究者

相似试验